Gene expression contributing to recruitment of circulating cells in response to vesicular stomatitis virus infection of the CNS

Viral Immunology

Volumn 19, Issue 3, 2006, Pages 536-545

  Ireland, Derek D C ^a,b   Reiss, Carol Shoshkes ^a,c,d  

^a NEW YORK UNIVERSITY   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN; CD8ALPHA ANTIGEN; CHEMOKINE; CYTOKINE; EOTAXIN; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; INTERFERON; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 12 RECEPTOR BETA2; INTERLEUKIN 12P40; INTERLEUKIN 16; INTERLEUKIN 18; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 23; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; UNINDEXED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL INFILTRATION; CELL TYPE; CENTRAL NERVOUS SYSTEM INFECTION; CONFERENCE PAPER; CYTOKINE PRODUCTION; GENE EXPRESSION; MALE; MOUSE; NATURAL KILLER CELL; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; T LYMPHOCYTE; VESICULAR STOMATITIS VIRUS;

ANIMALS; BRAIN; CENTRAL NERVOUS SYSTEM VIRAL DISEASES; CHEMOKINES; CYTOKINES; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NEUTROPHIL INFILTRATION; RHABDOVIRIDAE INFECTIONS; VESICULAR STOMATITIS-INDIANA VIRUS;

VESICULAR STOMATITIS VIRUS;

EID: 33750950146     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.2006.19.536     Document Type: Conference Paper

References (68)

1. Adler MW, and Rogers TJ: Are chemokines the third major system in the brain? J. Leukoc. Biol. 2005;78:1204-1209.
2. Asensio VC, and Campbell IL: Chemokine gene expression in the brains of mice with lymphocytic choriomeningitis. J. Virol. 1997;71:7832-7840.
3. Asensio VC, and Campbell IL: Chemokines in the CNS: plurifunctinal mediators in diverse states. Trends Neurosci. 1999;22:504-512.
4. Bi Z, Barna M, Komatsu T, and Reiss CS: Vesicular stomatitis virus infection of the central nervous system activates both innate and acquired immunity. J. Virol. 1995;69:6466-6472.
5. Bi Z, Quandt P, Komatsu T, Barna M, and Reiss CS: IL-12 promotes recovery from experimental CNS VSV infection. J. Immunol. 1995;155:5684-5689.
6. Bi Z, and Reiss CS: Inhibition of vesicular stomatitis virus infection by nitric oxide. J. Virol. 1995;69:2208-2213.
7. Bi Z, and CS Reiss: Interferon-γ-induced upregulation of type 1 nitric oxide synthase activity in neurons inhibits viral replication. In Stamler J, Gross S, Moncada S, and Higgs EA, eds. Biology of Nitric Oxide, Part 5. Portland Press, London, 1996, pp. 331-334.
8. Busfeld D, Nain M, Hofmann P, Gemsa D, and Sprenger H: Selective induction of the monocyte-attracting chemokines MCP-1 and IP-10 in vesicular stomatitis virus-infected human monocytes. J Interferon Cytokine Res. 2000;20:615-621.
9. Cheeran MC, Hu S, Sheng WS, Rashid A, Peterson PK, and Lokensgard JR: Differential responses of human brain cells to West Nile virus infection. J. Neurovirol. 2005;11:512-524.
10. Chen N, Restivo A, and Reiss CS: Leukotrienes promote recovery early during experimental VSV encephalitis. J. Neuroimmunol. 2001;120:94-102.
11. Chen N, and Reiss CS: Innate immunity in viral encephalitis: Role of C5. Viral Immunol. 2002;15:363-370.
12. Chesler DA, Dodard C, Lee GY, Levy D, and Reiss CS: The IFN-γ-induced antiviral response to VSV infection is STAT-1-dependent. J. Neurovirol. 2004;10:57-63.
13. Chesler DA, McCutcheon JA, and Reiss CS: The IFN-γ-induced antiviral response to VSV infection: Neuronal nitric oxide synthase expression is post-translationally regulated. J. Interferon Cytokine Res. 2004;24:141-149.
14. Chesler DA, and Reiss CS: IL-12, while beneficial, is not essential for the host response to VSV encephalitis. J. Neuroimmunol. 2002;131:92-97.
15. Chesler DA, and Reiss CS: The role of IFN-γ in immune responses to viral infections of the central nervous system. Cytokine Growth Factor Rev. 2002;13:441-454.
16. Christian AY, Barna M, Bi Z, and Reiss CS: Host immune response to vesicular stomatitis virus infection of the central nervous system in C57BL/6 mice. Viral Immunol. 1996;9:195-205.
17. Constantinuescu C, Frei K, Malipiero U, Rostami A, and Fontana A: Astrocytes and microglia produce IL-12. Ann. N. Y. Acad. Sci. 1996;795:328-333.
18. Cua DJ, Sherlock J, Chen Y, Murphy CA, Joyce B, Seymour B, Lucian L, To W, Kwan S, Churakova T, Zurawski S, Wiekowski M, Lira SA, Gorman D, Kastelein RA, and Sedgwick JD: IL-23, rather than IL-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 2003;421:744-748.
19. D'Andrea A, Rengaraju M, Valiante NM, Chehimi J, Kubin M, Aste M, Chan SH, Kobayashi M, Young D, Nickbarg E, et al.: Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells. J. Exp. Med. 1992;176:1387-1398.
20. Devi S, Laning J, Luo Y, and Dorf ME: Biologic activities of β-chemokine TCA3 on neutrophils and macrophages. J. Immunol. 1995;154:5376-5383.
21. dos Santos AC, Barsante MM, Esteves Arantes RM, Bernard CC, Teixeira MM, and Carvalho-Tavares J: CCL2 and CCL5 mediate leukocyte adhesion in experimental autoimmune encephalomyelitis: An intravital microscopy study. J. Neuroimmunol. 2005;162:122-129.
22. Doyle HA, and Murphy JW: Role of the C-C chemokine TCA3 in the protective anti-cryptococcal cell-mediated immune response. J. Immunol. 1999;162:4824-4833.
23. d system. J. Virol. 1991;65:4950-4958.
24. Gidday JM, Gasche YG, Copin JC, Shah AR, Perez RS, Shapiro SD, Chan PH, and Park TS: Leukocyte-derived matrix metalloproteinase-9 mediates blood-brain barrier breakdown and is proinflammatory after transient focal cerebral ischemia. Am. J. Physiol. Heart Circ. Physiol. 2005;289:H558-H568.
25. Glass WG, Chen BP, Liu MT, and Lane TE: Mouse hepatitis virus infection of the central nervous system: Chemokine-mediated regulation of host defense and disease. Viral Immunol. 2002;15:261-272.
26. Glass WG, Lim JK, Cholera R, Pletnev AG, Gao J-L, and Murphy PM: Chemokine receptor CCR5 promotes leukocyte trafficking to the brain and survival in West Nile virus infection. J. Exp. Med. 2005;202:1087-1098.
27. Hodges JL, Ireland DDC, and Reiss CS: IL-18 does not play a major role in VSV pathogenesis. Viral Immunol. 2001;14:181-191.
28. Hoffman LM, Fife BT, Begolka WS, Miller SD, and Karpus WJ: Central nervous system chemokine expression during Theiler's virus-induced demyelinating disease. J. Neurovirol. 1999;5:635-642.
29. Huneycutt BS, Bi Z, Aoki C, and Reiss CS: Central neuropathogenesis of vesicular stomatitis virus infection in immunodeficient mice. J. Virol. 1993;67:6698-6706.
30. Huneycutt BS, Plakhov IV, Schusterman Z, Huang AS, Reiss CS, and Aoki C: Distribution of vesicular stomatitis virus proteins in the brains of BALB/c mice: An immunohistochemical analysis. Brain Res. 1994;635:81-95.
31. Inglis VI, Jones MPJ, Tse ADY, and Easton AS: Neutrophils both reduce and increase permeability in a cell culture model of the blood-brain barrier. Brain Res. 2004;998:218-229.
32. Ireland DDC, Bang T, Komatsu T, and Reiss CS: Delayed administration of IL-12 is efficacious in promoting recovery from lethal viral encephalitis. Viral Immunol. 1999;12:35-40.
33. Ireland DDC, Palian B, and Reiss CS: IL-12Rβ1- or IL-12Rβ2-deficiency indicate that neither IL-12 nor IL-23 are essential for host recovery from viral encephalitis. Viral Immunol. 2005;18:397-402.
34. Ireland DDC, and Reiss CS: Neuronal expression of functional IL-12 receptors. Viral Immunol. 2004;17:411-422.
35. Komatsu T, Barna M, and Reiss CS: IL-12 promotes recovery from viral encephalitis. Viral Immunol. 1997;10:35-47.
36. Komatsu T, Bi Z, and Reiss CS: IFN-γ-induced type 1 nitric oxide synthase activity inhibits viral replication in neurons. J. Neuroimmunol. 1996;68:101-108.
37. Komatsu T, Ireland DDC, Chang N, Dore A, Yoder M, and Reiss CS: Regulation of the blood brain barrier during viral encephalitis: Roles of IL-12 and NOS. Nitric Oxide Biol. Chem. 1999;3:327-339.
38. Komatsu T, Ireland DDC, Chen N, and Reiss CS: Neuronal expression of NOS-1 is required for host recovery from viral encephalitis. Virology 1999;258:389-395.
39. Komatsu T, Ireland DDC, and Reiss CS: IL-12 and viral infections. Cytokine Growth Factor Rev. 1999;9:277-285.
40. Komatsu T, and Reiss CS: IFN-γ is important but not required for the IL-12-response to vesicular stomatitis virus infection of the olfactory bulb. J. Immunol. 1997;159:3444-3452.
41. Komatsu T, Srivastava N, Revzin M, Ireland DDC, Chesler D, and Reiss CS: Mechanisms of NO inhibition of viral replication. Virology 1999;259:334-341.
42. Minagar A, Shapshak P, Fujinami R, Ownby R, Heyes M, and Eisdorfer C: The role of macrophage/microglia in the pathogenesis of three neurological disorders: HIV-associated dementia, Alzheimer disease, and multiple sclerosis. J. Neurol. Sci. 2002;202:13-23.
43. Murphy CA, Hoek RM, Wiekowski MT, Lira SA, and Sedgwick JD: Interactions between hematopoietically derived TNF and central nervous system-resident glial chemokines underlie initiation of autoimmune inflammation in the brain. J. Immunol. 2002;169:7054-7062.
44. + T cells increase during viral infection and migrate to sites of infection. Eur. J. Immunol. 2000;30:1797-1806.
45. Olson IK, and Miller SD: Microglia initiate central nervous system innate and adaptive immune responses through TLRs. J. Immunol. 2004;173:3916-3924.
46. Oppmann B, Lesley R, Blom B, Timans IC, Xu Y, Hunte B, Vega F, Yu N, Wang J, Singh K, Zonin F, Vaisberg E, Churakova T, Liu M, German D, Wagner J, Zurawski S, Liu Y, Abrams JS, Moore KW, Rennick D, de Waal-Malefyt R, Hannum C, Bazan JF, and Kastelein RA: Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 2000;13:715-725.
47. Plakhov IV, Aoki C, Arlund E, and Reiss CS: The earliest events in vesicular stomatitis virus infection of the murine olfactory neuroepithelium and entry of the central nervous system. Virology 1995;209:257-262.
48. Plakhov IV, Aoki C, Reiss CS, and Huang AS: Pathogenesis of murine encephalitis is limited by defective interfering particles: An immunohistochemical study. J. Neurovirol. 1995;1:207-218.
49. Plakhov IV, Bi Z, Aoki C, and Reiss CS: The earliest events in vesicular stomatitis virus infection of the murine olfactory neuroepithelium and invasion of the central nervous system. ACLAD Newslett. 1995;16:7-8.
50. Raivich G, and Banati R: Brain microglia and blood-derived macrophages: Molecular profiles and functional roles in multiple sclerosis and animal models of autoimmune demyelinating disease. Brain Res. Brain Res. Rev. 2004;46:261-281.
51. Reiss CS, and Aoki C: Immunity to vesicular stomatitis virus. Rev. Med. Virol. 1994;4:129-140.
52. Reiss CS, Komatsu T, Barna M, and Bi Z: Interleukin-12 promotes enhanced recovery from viral infection of the central nervous system. Ann. N. Y. Acad. Sci. 1996;795:257-265.
53. Reiss CS, Plakhov IV, and Komatsu T: Viral replication in j olfactory receptor neurons and entry into the olfactory bulb and brain. Ann. N. Y. Acad. Sci. 1998;855:751-761.
54. Reiss CS, and Komatsu T: Does nitric oxide play a critical role in viral infections? Mini-review. J. Virol. 1998;72:4547-4551.
55. Reiss CS, Ireland DDC, Chesler DA, Plakhov IV, Chen N, Hodges JL, Samma MA, and Komatsu T: Pathogenesis of vesicular stomatitis virus encephalitis. In Pandalai G, ed. Recent Research Developments in Virology, Vol. 1, pp. 703-716. Transworld Research Network, Trivandrum, Kerala, India, 1999.
56. Reiss CS, Chesler DA, Hodges J, Ireland DDC, and Chen N: Innate immune responses in viral encephalitis. Curr Top. Microbiol. Immunol. 2002;265:63-94.
57. Rossi D, and Zlotnik A: The biology of chemokines and their receptors. Annu. Rev. Immunol. 2000;18:217.
58. Segal BM: CNS chemokines, cytokines, and dendritic cells in autoimmune demyelination. J. Neurol. Sci. 2005;228:210-214.
59. Stalder AK, Pagenstecher A, Yu NC, Kincaid C, Chiang CS, Hobbs MV, Bloom FE, and Campbell IL: Lipopolysaccharide-induced IL-12 expression in the central nervous system and cultured astrocytes and microglia. J. Immunol. 1997;159:1344-1351.
60. Suzumura A, Sawada M, and Takayanagi T: Production of interleukin-12 and expression of its receptors by murine microglia. Brain Res. 1998;787:139-142.
61. Taoufik Y, de Goer de Herve MG, Giron-Michel J, Durali D, Cazes E, Tardieu M, Azzarone B, and Delfraissy JF: Human microglial cells express a functional IL-12 receptor and produce IL-12 following IL-12 stimulation. Eur. J. Immunol. 2001;31:3228-3239.
62. Tran EH, Price EN, and Owens T: IFN-γ shapes immune invasion of the central nervous system via regulation of chemokines. J. Immunol. 2000;164:2759-2768.
63. Trinchieri G, Wysocka M, D'Andrea A, Rengaraju M, Aste-Amezaga M, Kubin M, Valiante NM, and Chehimi J: Natural killer cell stimulatory factor (NKSF) or interleukin-12 is a key regulator of immune response and inflammation. Prog. Growth Factor Res. 1992;4:355-368.
64. Trottier MD, Palian BM, and Reiss CS: VSV replication in neurons is inhibited by type I IFN at multiple stages of infection. Virology 2005;333:215-225.
65. Trottier MD, Poliquin L, Yang J, Lyles DS, and Reiss CS: Differential expression of type 1 interferon in the periphery and central nervous system of mice in response to vesicular stomatitis virus infection. (Submitted.)
66. Tsunoda I, Lane TE, Blackett J, and Fujinami RS: Distinct roles for IP-10/CXCL10 in three animal models: Theilers' virus infection, EAE, and MHV infection, for multiple sclerosis-implication of differing roles of IP-10. Mult. Scler. 2004;10:26-34.
67. Ubogu EE, Cossoy MB, and Ransohoff RM: The expression and function of chemokines involved in CNS inflammation. Trends Pharmacol. Sci. 2006;27:48-55.
68. Ure DR, Lane TE, Liu MT, and Rodriguez M: Neutralization of chemokines RANTES and MIG increases virus antigen expression and spinal cord pathology during Theiler's virus infection. Int. Immunol. 2005;17:569-579.